Guided Quasicontinuous Atom Laser

We report the first realization of a guided quasicontinuous atom laser by rf outcoupling a Bose-Einstein condensate from a hybrid optomagnetic trap into a horizontal atomic waveguide. This configuration allows us to cancel the acceleration due to gravity and keep the de Broglie wavelength constant at 0.5 $\mu$m during 0.1 s of propagation. We also show that our configuration, equivalent to pigtailing an optical fiber to a (photon) semiconductor laser, ensures an intrinsically good transverse mode matching.Comment: version published in Phys. Rev. Lett. 97, 200402 (2006

Measuring the Loschmidt amplitude for finite-energy properties of the Fermi-Hubbard model on an ion-trap quantum computer

Calculating the equilibrium properties of condensed matter systems is one of the promising applications of near-term quantum computing. Recently, hybrid quantum-classical time-series algorithms have been proposed to efficiently extract these properties from a measurement of the Loschmidt amplitude $\langle \psi| e^{-i \hat H t}|\psi \rangle$ from initial states $|\psi\rangle$ and a time evolution under the Hamiltonian $\hat H$ up to short times $t$. In this work, we study the operation of this algorithm on a present-day quantum computer. Specifically, we measure the Loschmidt amplitude for the Fermi-Hubbard model on a $16$-site ladder geometry (32 orbitals) on the Quantinuum H2-1 trapped-ion device. We assess the effect of noise on the Loschmidt amplitude and implement algorithm-specific error mitigation techniques. By using a thus-motivated error model, we numerically analyze the influence of noise on the full operation of the quantum-classical algorithm by measuring expectation values of local observables at finite energies. Finally, we estimate the resources needed for scaling up the algorithm.Comment: 18 pages, 12 figure

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

During the COVID-19 pandemic, SARS-CoV-2 infected millions of people and claimed hundreds of thousands of lives. Virus entry into cells depends on the receptor binding domain (RBD) of the SARS-CoV-2 spike protein (S). Although there is no vaccine, it is likely that antibodies will be essential for protection. However, little is known about the human antibody response to SARS-CoV-2. Here we report on 149 COVID-19 convalescent individuals. Plasmas collected an average of 39 days after the onset of symptoms had variable half-maximal pseudovirus neutralizing titres: less than 1:50 in 33% and below 1:1,000 in 79%, while only 1% showed titres above 1:5,000. Antibody sequencing revealed expanded clones of RBD-specific memory B cells expressing closely related antibodies in different individuals. Despite low plasma titres, antibodies to three distinct epitopes on RBD neutralized at half-maximal inhibitory concentrations (IC₅₀ values) as low as single digit nanograms per millitre. Thus, most convalescent plasmas obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity. Nevertheless, rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective